BlackRock Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-673,681
| Closed | -$317K | – | 3784 |
|
|
2016
Q1 | $317K | Sell |
673,681
-19,796
| -3% | -$9.32K | ﹤0.01% | 2271 |
|
|
2015
Q4 | $473K | Sell |
693,477
-20,846
| -3% | -$14.2K | ﹤0.01% | 2071 |
|
|
2015
Q3 | $693K | Sell |
714,323
-31,937
| -4% | -$31K | ﹤0.01% | 1926 |
|
|
2015
Q2 | $896K | Sell |
746,260
-47,473
| -6% | -$57K | ﹤0.01% | 1710 |
|
|
2015
Q1 | $841K | Hold |
793,733
| – | – | ﹤0.01% | 1646 |
|
|
2014
Q4 | $865K | Hold |
793,733
| – | – | ﹤0.01% | 1561 |
|
|
2014
Q3 | $857K | Sell |
793,733
-24,677
| -3% | -$26.6K | ﹤0.01% | 1504 |
|
|
2014
Q2 | $851K | Sell |
818,410
-22,058
| -3% | -$22.9K | ﹤0.01% | 1583 |
|
|
2014
Q1 | $866K | Buy |
840,468
+50,827
| +6% | +$52.4K | ﹤0.01% | 1617 |
|
|
2013
Q4 | $916K | Buy |
789,641
+5,744
| +0.7% | +$6.66K | ﹤0.01% | 1547 |
|
|
2013
Q3 | $1.32M | Sell |
783,897
-25,777
| -3% | -$43.3K | ﹤0.01% | 1282 |
|
|
2013
Q2 | $1.62M | Buy |
+809,674
| New | +$1.62M | ﹤0.01% | 1179 |
|